Home
Conditions
Communicable Diseases

Clinical trial condition

Communicable Diseases

Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.

9,158 public trials 553 recruiting studies

Refine in advanced search Browse all conditions

Communicable Diseases trial results

Completed

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

NCT03134833

Conditions: Behavior, Chemically-Induced Disorders, Communicable Diseases, +15 more
Locations: University of California, Los Angeles Los Angeles, California, United States

Tulane University Health Sciences Center New Orleans, Louisiana, United States

View Trial Details

Completed

ISIS 14803-CS2, Treatment With ISIS 14803, Administered IV in Patients With Chronic Hepatitis C Virus Infections

NCT00035945

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Isis Pharmaceuticals Carlsbad, California, United States

View Trial Details

Completed

HIV and STIs Clinical Study in Germany

NCT03884816

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +18 more
Locations: Praxis Dr. Cordes Berlin, Germany

Zentrum für Infektiologie Berlin Prenzlauer Berg (ZIBP) Berlin, Germany

Praxis Jessen Berlin, Germany

WIR "Walk In Ruhr" Bochum, Germany

View Trial Details

Completed

Prospective Observational Cohort HIV & STI Study in Europe

NCT03866759

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +19 more
Locations: Centre Hospitalier Universitaire de Bordeaux Bordeaux, France

Hôpital de la Croix-Rousse Lyon, France

Hospital Saint Louis Paris, France

Hôpital Lariboisière Paris, France

View all 15 locations

View Trial Details

Completed

Study of HIV, HCV, APS and Phylogenetics for PWID

NCT03447210

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations: Githurai Drop-in Centre Nairobi, Kenya

Ngara Health Centre Nairobi, Kenya

Pangani Drop-in Centre Nairobi, Kenya

View Trial Details

Completed

A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B

NCT01519960

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Univ of California SF, Benioff Children's Hospital; Pediatrics, Gastro, Hepatology & Nutrition San Francisco, California, United States

Johns Hopkins Hospital - Pediatric Gastroenterology Baltimore, Maryland, United States

Children's Hospital Boston-Harvard Medical School; Division of Gastoenterology Boston, Massachusetts, United States

St. Louis University - Cardinal Glennon Children's Medical Center St Louis, Missouri, United States

View all 39 locations

View Trial Details

Completed

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

NCT03361956

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: The Office of Franco Felizarta, MD Bakersfield, California, United States

Orlando Immunology Center Orlando, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

Tulane Medical Center (TMC) New Orleans, Louisiana, United States

View all 76 locations

View Trial Details

Completed

Navigating Insurance Coverage Expansion (NICE)

NCT04263441

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Howard Brown Health Chicago, Illinois, United States

Chicago House and Social Service Agency, Inc. Chicago, Illinois, United States

University of Chicago Medical Center Chicago, Illinois, United States

View Trial Details

Completed

Autologous CD4 T-Cells in HIV (C34-CXCR4)

NCT03020524

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

NCT02660905

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +26 more
Locations: The Ottawa Hospital, General Campus Ottawa, Ontario, Canada

The Research Institute of the McGill University Health Centre Montreal, Quebec, Canada

View Trial Details

Communicable Diseases

Communicable Diseases trial results

Related conditions